Reducing Central Line-Associated Bloodstream Infections Essay

Exclusively available on Available only on IvyPanda® Made by Human No AI

A central line-associated bloodstream infection (CLABSI) is an infection in the bloodstream that is unrelated to another site and that occurs within two days of central-line placement. These infections are relevant clinically in the United States because of the high costs associated with treating them and an intensive care unit (ICU) prevalence rate of 0.87(per 1,000 central line days) as of 2020 (Haddadin & Regunath, 2019). A majority of occurrences are preventable by adequate management strategies, surveillance, and aseptic techniques.

PICO Question

The problem I observed during my clinical placement was incidents of central line-associated bloodstream infection (CLABSI). This issue affected patients of all ages, and was associated with mortality, increased healthcare costs, and prolonged stays. Increased costs were the highest occurrence followed by prolonged stays and mortality was the least common. I especially noticed a problem with hosts with pre-existing risk factors, including extremes of age, total parenteral nutrition, malnutrition, immune-suppressed states, gastrointestinal tract disorders, malignancy, and chronic illnesses.

Intervention

The best intervention under consideration for this case is using best practices and following evidence-based guidelines. This approach will feature two mechanisms; using a central-line insertion checklist and monitoring adherence. The checklist will contain extensive details about the actions that have to be taken before, during, and post-central line insertion. The monitoring mechanism will involve looking at the total number of daily conventional central venous catheters (CVC) insertions. The process will involve implementing daily unit logs and accompanying central line insertion practice forms (CLIP forms). Compliance will be calculated by dividing total CHIP forms by total newly-inserted CVCs. This will be followed by weekly reports and feedback to practitioners that will be followed by appropriate action. The logs will track the insertions performed on a given day while the CLIP forms will act as proof that the practitioner followed the checklist. Monitoring will also include regular staff checks on patients to determine if central lines are still needed with the objective of removing them as soon as possible.

Comparison

One plausible alternative that can be used is using supply bundles and kits. Many errors are the result of interruptions during the CVC insertion process as nurses have to move around looking for different materials. Doing this exposes patients to infections because their wounds are left open to entrance by bacteria. The goal with this intervention is making sure practitioners have all the materials and supplies they need in one place and easily accessible. The best part about this alternative is that it can also be used as supplementary to those interventions mentioned above. However, it does not compare as well because the main interventions are more specific as they include the specific steps and directives.

Outcomes

The goal is to reduce the incidence of central line-associated bloodstream infections (CLABSI) in ICU units at the practice. The idea is to prevent occurrences and facilitate timely treatment. The checklists and monitoring will look to ensure bacteria does not enter the bloodstream and create an environment that discourages their growth. Regular monitoring will allow the staff to detect infections early when they can be treated effectively and at a lower cost.

Time Limit

This project will take three months and involve four phases; assessment, implementation, assessment, and evaluation. The assessment phase will come first followed by implementation and assessment that will run simultaneously before evaluation. The first phase will take one month, the second and third six weeks and the last two weeks. Assessment will take a month because CLABSI is rare and it will take time to have a clear picture of what is going on. Implementation and assessment will run for six weeks for similar reasons and will mainly involve looking at compliance. The evaluation phase will come after two months and two weeks because this period is significant enough to avail the comprehensive data like total cost, occurrences, and prevalence needed to develop actionable insights.

Review of Literature

A substantial amount of research has gone into how to minimize central line-associated bloodstream infections (CLABSI). Patel et al. (2018) conducted a systematic review for the most used interventions and found that the most effective ones addressed multiple stages and involved auditing and feedback processes. Wichmann et al. (2018) found that checklists met that criteria and were effective in reducing CLABSI frequency. Other studies have identified other alternatives to reducing CLABSI incidences. For instance, using antiseptic barrier caps is also effective in lowering the rate (Voor et al., 2017). Other studies found evidence that supports the alternative intervention identified above. Payne et al. (2017) reviewed literature on the efficacy of using care bundles in reducing the CLABSI incidents in neonatal ICUs and found they reduced occurrences significantly.

The problem under consideration is incidents of central line-associated bloodstream infections (CLABSI) in the ICU. These infections are associated with prolonged hospital stays, increased health care costs, and mortalities. The suggested interventions are using a central-line insertion checklist and monitoring adherence. An alternative would be using supply bundles and kits to make materials easy to access. The goal is to reduce the number and severity of incidents. Research shows that the best interventions are compound and include auditing and feedback.

References

Haddadin, Y., & Regunath, H. (2019). . Nih.gov; StatPearls Publishing.

Patel, P. K., Gupta, A., Vaughn, V. M., Mann, J. D., Ameling, J. M., & Meddings, J. (2018). Journal of hospital medicine, 13(2), 105-116.

Payne, V., Hall, M., Prieto, J., & Johnson, M. (2018). Archives of Disease in Childhood-Fetal and Neonatal Edition, 103(5), F422-F429.

Voor, A. F., Helder, O. K., Vos, M. C., Schafthuizen, L., Sülz, S., van den Hoogen, A., & Ista, E. (2017). . International journal of nursing studies, 69, 34-40.

Wichmann, D., Belmar Campos, C. E., Ehrhardt, S., Kock, T., Weber, C., Rohde, H., & Kluge, S. (2018). . BMC infectious diseases, 18(1), 1-6.

More related papers Related Essay Examples
Cite This paper
You're welcome to use this sample in your assignment. Be sure to cite it correctly

Reference

IvyPanda. (2023, August 16). Reducing Central Line-Associated Bloodstream Infections. https://ivypanda.com/essays/reducing-central-line-associated-bloodstream-infections/

Work Cited

"Reducing Central Line-Associated Bloodstream Infections." IvyPanda, 16 Aug. 2023, ivypanda.com/essays/reducing-central-line-associated-bloodstream-infections/.

References

IvyPanda. (2023) 'Reducing Central Line-Associated Bloodstream Infections'. 16 August.

References

IvyPanda. 2023. "Reducing Central Line-Associated Bloodstream Infections." August 16, 2023. https://ivypanda.com/essays/reducing-central-line-associated-bloodstream-infections/.

1. IvyPanda. "Reducing Central Line-Associated Bloodstream Infections." August 16, 2023. https://ivypanda.com/essays/reducing-central-line-associated-bloodstream-infections/.


Bibliography


IvyPanda. "Reducing Central Line-Associated Bloodstream Infections." August 16, 2023. https://ivypanda.com/essays/reducing-central-line-associated-bloodstream-infections/.

If, for any reason, you believe that this content should not be published on our website, please request its removal.
Updated:
This academic paper example has been carefully picked, checked and refined by our editorial team.
No AI was involved: only quilified experts contributed.
You are free to use it for the following purposes:
  • To find inspiration for your paper and overcome writer’s block
  • As a source of information (ensure proper referencing)
  • As a template for you assignment
Privacy Settings

IvyPanda uses cookies and similar technologies to enhance your experience, enabling functionalities such as:

  • Basic site functions
  • Ensuring secure, safe transactions
  • Secure account login
  • Remembering account, browser, and regional preferences
  • Remembering privacy and security settings
  • Analyzing site traffic and usage
  • Personalized search, content, and recommendations
  • Displaying relevant, targeted ads on and off IvyPanda

Please refer to IvyPanda's Cookies Policy and Privacy Policy for detailed information.

Required Cookies & Technologies
Always active

Certain technologies we use are essential for critical functions such as security and site integrity, account authentication, security and privacy preferences, internal site usage and maintenance data, and ensuring the site operates correctly for browsing and transactions.

Site Customization

Cookies and similar technologies are used to enhance your experience by:

  • Remembering general and regional preferences
  • Personalizing content, search, recommendations, and offers

Some functions, such as personalized recommendations, account preferences, or localization, may not work correctly without these technologies. For more details, please refer to IvyPanda's Cookies Policy.

Personalized Advertising

To enable personalized advertising (such as interest-based ads), we may share your data with our marketing and advertising partners using cookies and other technologies. These partners may have their own information collected about you. Turning off the personalized advertising setting won't stop you from seeing IvyPanda ads, but it may make the ads you see less relevant or more repetitive.

Personalized advertising may be considered a "sale" or "sharing" of the information under California and other state privacy laws, and you may have the right to opt out. Turning off personalized advertising allows you to exercise your right to opt out. Learn more in IvyPanda's Cookies Policy and Privacy Policy.

1 / 1